title: Ultrasensitive measurement of protein and nucleic Acid biomarkers for earlier disease detection and more effective therapies.
abstract: Clinical decision making stands to benefit from ultrasensitive molecular diagnostic tools that identify disease-related changes in biomarker levels before advanced clinical signs and symptoms manifest.
authors: Chief Medical Officer, Nanosphere Inc., Northbrook, Ill.
authors: Gregory
authors: G
authors: Shipp